The results obtained demonstrated that CX3CL1+ and CX3CR1+ cells localized to fibroblastic foci in SKG-ILD and that the anti-CX3CL1 mAb treatment reduced the number of M1 macrophages in BALF. The gene discussed is CX3CR1; the disease is interstitial lung disease.